David Meyronet

Summary

Affiliation: Hospices Civils de Lyon
Country: France

Publications

  1. doi request reprint Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma
    David Meyronet
    INSERM, U842, Lyon, F 69372, France
    Am J Surg Pathol 32:1699-708. 2008
  2. doi request reprint The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study
    David Meyronet
    INSERM U1028 CNRS UM5292 Lyon Neuroscience Research Center, Neuro oncology and Neuro inflammation Team, 69000, Lyon, France
    J Neural Transm (Vienna) 122:975-91. 2015
  3. ncbi request reprint Focal myositis associated with S-1 radiculopathy: report of two cases
    Nathalie Streichenberger
    Service de Neuropathologie, Hopital Neurologique, BP Lyon Montchat, 69394 Lyon, France
    Muscle Nerve 29:443-6. 2004
  4. ncbi request reprint [Thymic neuroendocrine tumors: report on 6 cases]
    Lara Chalabreysse
    Service d Anatomie et de Cytologie Pathologiques, Hopital Louis Pradel, 28 avenue du Doyen Lepine, 69677 Bron Cedex
    Ann Pathol 25:205-10. 2005
  5. doi request reprint Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation
    Sébastien Brot
    INSERM, UMR S1028, CNRS, UMR 5292, Lyon Neuroscience Research Center, Neuro oncology and Neuro inflammation Team, 7, Rue Guillaume Paradin, Lyon Cedex 08 F 69372, France
    Exp Cell Res 319:588-99. 2013
  6. doi request reprint CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma
    Aurélien Viaccoz
    Neuro Oncology Department, Hospices Civils de Lyon, Hopital Neurologique, Bron, France A V, F D, L T M, S C C, J H INSERM U1028 CNRS UMR 5292, Lyon Neuroscience Research Center, Lyon, France A V, F D, Y T, G K B, L T M, D M, I Q, J H, A P L Université de Lyon, Universite Claude Bernard Lyon 1, Lyon, France A V, F D, L T M, J H Neurochemistry Unit, Biochemistry Department, Hospices Civils de Lyon, Hopital Neurologique, Bron, France Y T, I Q, A P L Department of Anesthesiology, Pharmacology and Intensive Care, Geneva University Hospitals, Germany
    Neuro Oncol 17:1497-503. 2015
  7. doi request reprint CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling
    Aubin Moutal
    INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro oncology and Neuro inflammation Team, University Claude Bernard Lyon 1, Lyon, France
    Cancer Res 75:3519-28. 2015
  8. doi request reprint [National network of paediatric central nervous system tumours reviewing by the Groupe d'Étude de Neuropathologie Oncologique Pediatrique (GENOP)]
    David Meyronet
    Neuro oncology and Neuro inflammation Team, INSERM U1028, CNRS UMR 5292, University Lyon 1, Neuroscience Center, 69000 Lyon, France
    Ann Pathol 34:74-86. 2014
  9. doi request reprint Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease
    Aline Dorey
    Hospices Civils de Lyon, Lyon 1 University, Hôpital des Charpennes, Center for Memory Resources and Research, Villeurbanne, France2Hospices Civils de Lyon, Groupement Hospitalier Est, Department of Biochemistry, Neurochemistry Unit, Lyon, France
    JAMA Neurol 72:267-75. 2015
  10. pmc Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells
    Sophie Kusy
    IPBC, CNRS UMR 6187, Faculté des Sciences de Poitiers, 40 Avenue du Recteur Pineau, Poitiers 86022, France
    Neoplasia 7:457-65. 2005

Collaborators

  • François Ducray
  • Dominique Figarella-Branger
  • Claude Alain Maurage
  • Roger Besancon
  • Emmanuel Jouanneau
  • Jacques Guyotat
  • Daniel Chan
  • J Honnorat
  • N Streichenberger
  • L Chalabreysse
  • Isabelle Quadrio
  • Aline Dorey
  • Yannick Tholance
  • Aurélien Viaccoz
  • Aubin Moutal
  • Armand Perret-Liaudet
  • Céline Malleval
  • Sébastien Brot
  • Sophie Kusy
  • Anne Gentil Perret
  • Ingolf Lachman
  • Marie Eve Mayeur
  • Guy Louis-Tisserand
  • Pierre Krolak-Salmon
  • Alain Vighetto
  • Uta Wagner
  • Nicolas Naudet
  • Gleicy Keli Barcelos
  • Naura Chounlamountri
  • Stéphanie Cartalat-Carel
  • Gabor G Kovacs
  • Laure Thomas-Maisonneuve
  • Pauline Désormeaux
  • Rajesh Khanna
  • Nicole Thomasset
  • Herve Ghesquieres
  • Caroline Bertrand
  • Patrick Massoma
  • Willy Zorzi
  • Sebastiaan Engelborghs
  • Chantal Watrin
  • Peter P De Deyn
  • Lea Magadoux
  • Hanne Struyfs
  • Benaissa El-Moualij
  • Carole Auger
  • Mahnaz Moradi-Améli
  • Claire Benetollo
  • Veronique Rogemond
  • Robert M Gemmill
  • Joëlle Roche
  • Bruno Constantin
  • Patrick Nasarre
  • Vincent Potiron
  • Harry A Drabkin
  • Yves Chavrier
  • Claire Berger

Detail Information

Publications11

  1. doi request reprint Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma
    David Meyronet
    INSERM, U842, Lyon, F 69372, France
    Am J Surg Pathol 32:1699-708. 2008
    ..Our findings point at CRMP5 as a novel marker for routine pathologic evaluation of lung tumors surgical samples in distinguishing between highly aggressive neuroendocrine carcinoma and the other lung cancers...
  2. doi request reprint The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study
    David Meyronet
    INSERM U1028 CNRS UM5292 Lyon Neuroscience Research Center, Neuro oncology and Neuro inflammation Team, 69000, Lyon, France
    J Neural Transm (Vienna) 122:975-91. 2015
    ..However, the entire process has to be envisioned from the autopsy to the analysis. The impact on protein or nucleic acid quality is a limitation that restricts the amount of samples available for this purpose. ..
  3. ncbi request reprint Focal myositis associated with S-1 radiculopathy: report of two cases
    Nathalie Streichenberger
    Service de Neuropathologie, Hopital Neurologique, BP Lyon Montchat, 69394 Lyon, France
    Muscle Nerve 29:443-6. 2004
    ..Muscle biopsy revealed a focal myositis associated with some features of denervation. A brief course of corticosteroids was followed by remission clinically and improvement in the MRI findings...
  4. ncbi request reprint [Thymic neuroendocrine tumors: report on 6 cases]
    Lara Chalabreysse
    Service d Anatomie et de Cytologie Pathologiques, Hopital Louis Pradel, 28 avenue du Doyen Lepine, 69677 Bron Cedex
    Ann Pathol 25:205-10. 2005
    ..the aim of our study was to analyze a series of 6 thymic neuroendocrine tumors (TNET)...
  5. doi request reprint Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation
    Sébastien Brot
    INSERM, UMR S1028, CNRS, UMR 5292, Lyon Neuroscience Research Center, Neuro oncology and Neuro inflammation Team, 7, Rue Guillaume Paradin, Lyon Cedex 08 F 69372, France
    Exp Cell Res 319:588-99. 2013
    ..Moreover, we show that the function associated with the CRMP5 nuclear targeting is an increase of cell proliferation activity...
  6. doi request reprint CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma
    Aurélien Viaccoz
    Neuro Oncology Department, Hospices Civils de Lyon, Hopital Neurologique, Bron, France A V, F D, L T M, S C C, J H INSERM U1028 CNRS UMR 5292, Lyon Neuroscience Research Center, Lyon, France A V, F D, Y T, G K B, L T M, D M, I Q, J H, A P L Université de Lyon, Universite Claude Bernard Lyon 1, Lyon, France A V, F D, L T M, J H Neurochemistry Unit, Biochemistry Department, Hospices Civils de Lyon, Hopital Neurologique, Bron, France Y T, I Q, A P L Department of Anesthesiology, Pharmacology and Intensive Care, Geneva University Hospitals, Germany
    Neuro Oncol 17:1497-503. 2015
    ..The aim of this study was to investigate the diagnostic value of CSF neopterin, a marker of neuroinflammation, in immunocompetent patients with suspected PCNSL...
  7. doi request reprint CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling
    Aubin Moutal
    INSERM U1028, CNRS UM5292, Lyon Neuroscience Research Center, Neuro oncology and Neuro inflammation Team, University Claude Bernard Lyon 1, Lyon, France
    Cancer Res 75:3519-28. 2015
    ....
  8. doi request reprint [National network of paediatric central nervous system tumours reviewing by the Groupe d'Étude de Neuropathologie Oncologique Pediatrique (GENOP)]
    David Meyronet
    Neuro oncology and Neuro inflammation Team, INSERM U1028, CNRS UMR 5292, University Lyon 1, Neuroscience Center, 69000 Lyon, France
    Ann Pathol 34:74-86. 2014
    ..Inter-observer agreement varied according to the tumour subtypes. ..
  9. doi request reprint Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease
    Aline Dorey
    Hospices Civils de Lyon, Lyon 1 University, Hôpital des Charpennes, Center for Memory Resources and Research, Villeurbanne, France2Hospices Civils de Lyon, Groupement Hospitalier Est, Department of Biochemistry, Neurochemistry Unit, Lyon, France
    JAMA Neurol 72:267-75. 2015
    ..The major biological diagnostic biomarker for identifying CJD, 14-3-3 protein in cerebrospinal fluid (CSF), unfortunately lacks specificity when confronting a rapid dementia presentation...
  10. pmc Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells
    Sophie Kusy
    IPBC, CNRS UMR 6187, Faculté des Sciences de Poitiers, 40 Avenue du Recteur Pineau, Poitiers 86022, France
    Neoplasia 7:457-65. 2005
    ..Thus, in this in vivo lung cancer model, SEMA3F has potent antitumor effects, which may impinge on activated integrin and MAPK signaling...
  11. ncbi request reprint [A pseudo aneurysmal subcutaneous tumor]
    Anne Gentil Perret
    Service d Anatomie et de Cytologie Pathologiques, CHU, 42055 de Saint Etienne
    Ann Pathol 23:73-5. 2003